Industry & Policy News

[BioSpace (Celltrion USA)] ZYMFENTRA® for maintenance therapy in adults with moderately to severely active ulcerative colitis and Crohn’s disease following treatment with an infliximab product administered intravenously.

[The University of Tennessee Health Science Center] Drs. Duane Miller, left, and Ramesh Narayanan, have developed a drug candidate for advanced metastatic prostate cancer that is in its first clinical trial and has received fast-track status from the US FDA, potentially accelerating its clinical development.

[Harvard Medical School] Gregory Petsko, Harvard Medical School professor of neurology at Brigham and Women’s Hospital, has been awarded a 2022 National Medal of Science.

[Vanderbilt University] The National Institutes of Health has awarded a $4.1 million grant to Vanderbilt University Medical Center and University of California, San Diego to better understand the mechanism behind the association between preeclampsia and other hypertensive disorders of pregnancy and cardiovascular disease.

[Pharma Equity Group A/S] Pharma Equity Group's subsidiary, Reponex Pharmaceuticals, announced that the European Patent Office has issued an "Intention To Grant" for EU patent applications numbers 15724673.7 and 19701467.3.

[Pharma Equity Group A/S] Pharma Equity Group's subsidiary, Reponex Pharmaceuticals, announced that the European Patent Office has issued an "Intention To Grant" for EU patent applications numbers 15724673.7 and 19701467.3.